Research map: CHEK2 Germline Gene Variant in a Patient with a Somatotrophinoma and Primary Hyperparathyroidism – A Novel MEN1-like Syndrome?

Back to the article

Papers in this map

  1. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations · Hanne E.J. Meijers-Heijboer · 2002 · 1113 citations · Cited by this paper
  2. HbA1c screening in patients with early breast cancer receiving endocrine therapy · 2025 · Related
  3. Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome · Daphne W. Bell · 1999 · 908 citations · Cited by this paper
  4. Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas · 2025 · Related
  5. Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary Hyperparathyroidism · Nathan Anthony Johnson · 2007 · 367 citations · Cited by this paper
  6. Risk of bowel ischemia in patients with mesenteric neuroendocrine tumors after treatment with 177Lu-DOTATATE · 2025 · Related
  7. Epidemiology of acromegaly: review of population studies · Aikaterini Lavrentaki · 2016 · 355 citations · Cited by this paper
  8. 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence · 2025 · Related
  9. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate · Lenka Stolařová · 2020 · 199 citations · Cited by this paper
  10. Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes · 2025 · Related
  11. Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1 · Behnam Asgharian · 2004 · 127 citations · Cited by this paper
  12. To screen or not to screen: complexity of SDHA mutation management · 2026 · Related
  13. Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53 · Kaoru Tominaga · 1999 · 100 citations · Cited by this paper
  14. Adrenal crisis due to pembrolizumab-induced hypophysitis in a patient with triple-negative breast cancer · 2025 · Related
  15. Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) · HELEN LOUISE HANSON · 2023 · 90 citations · Cited by this paper
  16. Using routinely collected patient data to study the impact of type 2 diabetes on breast cancer · 2025 · Related
  17. Surgeon-Performed Ultrasound Is Superior to 99Tc-Sestamibi Scanning to Localize Parathyroid Adenomas in Patients with Primary Hyperparathyroidism: Results in 516 Patients over 10 Years · Brian R. Untch · 2011 · 89 citations · Cited by this paper
  18. Patient-reported symptom and urgent healthcare use in neuroendocrine tumors · 2026 · Related
  19. The genetic background of acromegaly · Mônica R. Gadelha · 2017 · 87 citations · Cited by this paper
  20. Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute · 2025 · Related
  21. The Genetics of Pituitary Adenomas · Christina Tatsi · 2019 · 75 citations · Cited by this paper
  22. Genetics of Acromegaly and Gigantism · Anna Bogusławska · 2021 · 70 citations · Cited by this paper
  23. Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein ( AIP ) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations · Susana Igreja · 2008 · 68 citations · Cited by this paper
  24. Molecular genetic testing in the management of pituitary disease · Eva C Coopmans · 2022 · 46 citations · Cited by this paper
  25. Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly · Lisa B. Nachtigall · 2020 · 38 citations · Cited by this paper
  26. Skin cancer risk in CHEK2 mutation carriers · Ai‐Tram N. Bui · 2020 · 22 citations · Cited by this paper
  27. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas · Renata Kikuchi Foltran · 2018 · 16 citations · Cited by this paper
  28. Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation · Changqing Xie · 2018 · 15 citations · Cited by this paper
  29. Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias · Raphaelle D. Vallera · 2022 · 10 citations · Cited by this paper
  30. CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report · Anna Szeliga · 2020 · 9 citations · Cited by this paper
  31. Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas · Sunita M C De Sousa · 2024 · 8 citations · Cited by this paper
  32. Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort · Gustavo F C Fagundes · 2024 · 8 citations · Cited by this paper
  33. Delayed Craniospinal Metastasis of Aggressive Nonfunctioning Pituitary Adenomas as Pituitary Carcinomas · Ashley L. B. Raghu · 2021 · 7 citations · Cited by this paper
  34. False-negative 99mTc-sestamibi scans: factors and outcomes in primary hyperparathyroidism · Budoor Alemadi · 2024 · 6 citations · Cited by this paper
  35. Association of primary hyperparathyroidism with pituitary adenoma and management issues · Liza Das · 2025 · 4 citations · Cited by this paper
  36. The landscape of germline variants in breast and colorectal cancer susceptibility genes in patients with pituitary tumours · Andreas Orsmond · 2025 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)